Form D · Pharmaceuticals
Sagent Holding Co.
Schaumburg, IL · CIK 0001369786
Offering snapshot reported Sep 14, 2010 · SEC filing
- Reported sold
- $6M Offering amount: $6M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 3, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2010 | Initial | $5,999,998 | No comparison | 2 | SEC filing |
| Apr 5, 2010 | Initial | $9,800,000 | No comparison | 1 | SEC filing |
| Jun 2, 2009 | Initial | $30,000,000 | No comparison | Not reported | SEC filing |
| Jun 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-147701
Series B-1 Preference Shares
Source: Form D, filed Sep 14, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Flanagan | Director |
| Anthony Krizman | Director |
| Frank Kung | Director |
| Ronald Pauli | Executive |
| Mark Qiu | Director |
| James Sperans | Director |
| Jeffrey Yordon | Director, Executive |
| Chen Yu | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1901 North Roselle Road, Suite 700
Schaumburg, IL, 60195
Schaumburg, IL, 60195